Value Research Rating

4 star

Quality Score fund-quick-summary-circle

Quality Score8/10

Growth Score fund-quick-summary-circle

Growth Score6/10

Valuation Score fund-quick-summary-circle

Valuation Score2/10

Momentum Score fund-quick-summary-circle

Momentum Score10/10

Divi's Laboratories Ltd. Share Price

High:loading Low:loading Return: loading

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...

Stock Range

Today’s Range
Low: 6,020.35 High: 6,275.85
52 Week Range
Low: 3,295.30 High: 6,275.85
Liquidityliquidity High
Low Moderate High

Fundamentals

  • Market cap

    ₹1,62,131 Cr

  • P/E Ratio

    96.85

  • P/B Ratio

    11.58

  • Industry P/E

    62.09

  • Debt to Equity

    0

  • ROE

    12.15 %

  • ROCE

    16.46 %

  • Div. Yield

    0.87 %

  • Book Value

    512.11

  • EPS

    60.38

Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Divi's Lab
56.43 11.06 34.53 63.48 4.36 29.39 21.34
BSE Sensex
13.26 -1.29 1.62 23.44 10.10 16.45 12.00
BSE Healthcare
41.84 0.99 16.54 58.12 19.17 29.56 12.67
As on 15-Oct-2024
2023
2022
2021
2020
2019
2018
2017
Divi's Lab
14.38 -27.04 21.54 111.23 25.10 34.90 40.15
BSE Sensex
18.74 4.44 21.99 15.75 14.38 5.87 27.91
BSE Healthcare
36.97 -12.10 20.87 61.45 -3.55 -5.89 0.49

Valuation Score

Stock
Peer Median
loading...

Growth & Efficiency

Stock
Peer Median
loading...

Essential Checks View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials Detailed View

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Peer Comparison Comparison Details

search
search
search
search
    loading...

    Shareholding Pattern Detailed Holdings

    News & Analysis All News

    Other details More Details

    Incorporated

    1990

    Chairman

    Ramesh BV Nimmagadda

    Managing Director

    Murali K Divi

    Group

    Divis Labs

    Headquarters

    Hyderabad, Telangana
    Edit peer-selector-edit
    loading...
    loading...
    loading...
    loading...

    Key Facts

    • Market cap market-cap-information ₹1,62,130.95 Cr
    • Revenue (TTM)revenue-information ₹8,185.00 Cr
    • Earnings (TTM) earning-information ₹1,674.00 Cr
    • Cash date-information ₹3,980.00 Cr
    • Total Debt info ₹0.00 Cr
    • Promoters' ownership promoters_ownership 51.89%
    • Liquidity liquidity High
    • 52 Week range week-range ₹3,295.30 - 6,275.85
    • Face value face-value ₹2.00
    • Shares outstanding share-outstanding 26,54,68,580
    • 10 Years Aggregate:

      CFO: ₹13,539.39 Cr

      EBITDA: ₹20,307.87 Cr

      Net Profit: ₹15,012.76 Cr

    About The Company

    • Incorporated 1990
    • Chairman Ramesh BV Nimmagadda
    • Managing Director Murali K Divi
    • Group Divis Labs
    • Listing key-listing BSE: 532488, NSE: DIVISLAB
    • Country India
    • Headquarters headquarters Hyderabad, Telangana
    • Website website www.divislabs.com
    • Business

      Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, North America, Asia, Europe, and internationally. It also undertakes custom...  synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad, India.  Read more

    FAQs for Divi's Laboratories Ltd.

    The total asset value of Divi's Laboratories Ltd stood at ₹ 15,937 Cr as on 31-Mar-24

    The share price of Divi's Laboratories Ltd is ₹6,106.70 (NSE) and ₹6,107.35 (BSE) as of 15-Oct-2024 IST. Divi's Laboratories Ltd has given a return of 4.36% in the last 3 years.

    Divi's Laboratories Ltd has a market capitalisation of ₹ 1,62,131 Cr as on 15-Oct-2024. As per Value Research classification, it is a Large Cap company.

    The P/B ratio of Divi's Laboratories Ltd is 11.58 times as on 15-Oct-2024, a 157% premium to its peers’ median range of 4.51 times.

    The P/E ratio of Divi's Laboratories Ltd is 96.85 times as on 15-Oct-2024, a 56% premium to its peers’ median range of 62.09 times.

    Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
    Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
    Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
    Step 4. Search for the Divi's Laboratories Ltd and enter the required number of quantities and click on buy to purchase the shares of Divi's Laboratories Ltd.

    Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, North America, Asia, Europe, and internationally. It also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad, India.

    The prominent promoters of Divi's Laboratories Ltd. are

    Name of promoters Holding percentage

    NILIMA PRASAD DIVI

    20.34%

    SATCHANDRA KIRAN DIVI

    20.34%

    SWARNA LATHA DIVI

    5.27%
    Click here to see the full list

    The chairman of the company is Ramesh BV Nimmagadda, and the managing director is Murali K Divi.

    There is no promoter pledging in Divi's Laboratories Ltd.

    Some of the close peers are:

    Company Market Cap(₹ Cr)
    27,684
    19,848
    18,306
    14,427
    Divi's Laboratories Ltd. Ratios
    Return on equity(%)
    12.15
    Operating margin(%)
    23.3
    Net Margin(%)
    19.55
    Dividend yield(%)
    0.87

    Yes, TTM profit after tax of Divi's Laboratories Ltd was ₹1,674 Cr.